Cargando…

CRISPR-Associated (CAS) Effectors Delivery via Microfluidic Cell-Deformation Chip

Identifying new and even more precise technologies for modifying and manipulating selectively specific genes has provided a powerful tool for characterizing gene functions in basic research and potential therapeutics for genome regulation. The rapid development of nuclease-based techniques such as C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peyravian, Noshad, Malekzadeh Kebria, Maziar, Kiani, Jafar, Brouki Milan, Peiman, Mozafari, Masoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226447/ https://www.ncbi.nlm.nih.gov/pubmed/34207502 http://dx.doi.org/10.3390/ma14123164

Ejemplares similares

Stem cell therapy for COVID-19 pneumonia
por: Kebria, Maziar Malekzadeh, et al.
Publicado: (2022)

Copper-enriched diamond-like carbon coatings promote regeneration at the bone–implant interface
por: Milan, Peiman Brouki, et al.
Publicado: (2020)

Microfluidic Cell Deformability Assay for Rapid and Efficient Kinase Screening with the CRISPR‐Cas9 System
por: Han, Xin, et al.
Publicado: (2016)

CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer
por: Azangou-Khyavy, Mohammadreza, et al.
Publicado: (2020)

The effect of sodium selenite on apoptotic gene expression and development of in vitro cultured mouse oocytes in comparison with in vivo obtained oocytes
por: Malekzadeh Kebria, Maziar, et al.
Publicado: (2020)

Defining the seed sequence of the Cas12b CRISPR-Cas effector complex
por: Jain, Ishita, et al.
Publicado: (2018)

Effect of Interfacial Interaction on the Demolding Deformation of Injection Molded Microfluidic Chips
por: Wang, Yilei, et al.
Publicado: (2022)

CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation
por: Han, Xin, et al.
Publicado: (2015)

Structure of the type V-C CRISPR-Cas effector enzyme
por: Kurihara, Nina, et al.
Publicado: (2022)

Human Olfactory Mucosa Stem Cells Delivery Using a Collagen Hydrogel: As a Potential Candidate for Bone Tissue Engineering
por: Simorgh, Sara, et al.
Publicado: (2021)

Comparison of PDMS and NOA Microfluidic Chips: Deformation, Roughness, Hydrophilicity and Flow Performance
por: Turcitu, Tatiana, et al.
Publicado: (2023)

Interfering with retrotransposition by two types of CRISPR effectors: Cas12a and Cas13a
por: Zhang, Niubing, et al.
Publicado: (2020)

Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus
por: Majumdar, Sonali, et al.
Publicado: (2015)

PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures
por: Gleditzsch, Daniel, et al.
Publicado: (2018)

The diverse arsenal of type III CRISPR–Cas-associated CARF and SAVED effectors
por: Steens, Jurre A., et al.
Publicado: (2022)

CRISPR-Cas effector specificity and cleavage site determine phage escape outcomes
por: Schelling, Michael A., et al.
Publicado: (2023)

Study of individual erythrocyte deformability susceptibility to INFeD and ethanol using a microfluidic chip
por: Liu, Lihong, et al.
Publicado: (2016)

RNA-activated DNA cleavage by the Type III-B CRISPR–Cas effector complex
por: Estrella, Michael A., et al.
Publicado: (2016)

Bio-Layer Interferometry Analysis of the Target Binding Activity of CRISPR-Cas Effector Complexes
por: Müller-Esparza, Hanna, et al.
Publicado: (2020)

Mechanistic and evolutionary insights into a type V-M CRISPR–Cas effector enzyme
por: Omura, Satoshi N., et al.
Publicado: (2023)

Insights into the Role of Matrix Metalloproteinases in Precancerous Conditions and in Colorectal Cancer
por: Pezeshkian, Zahra, et al.
Publicado: (2021)

Tissue-engineered small-diameter vascular grafts containing novel copper-doped bioactive glass biomaterials to promote angiogenic activity and endothelial regeneration
por: Alasvand, Neda, et al.
Publicado: (2023)

A Novel Intervention Technology for Cerebral Palsy: Brain Stimulation
por: RAMEZANI, Sara, et al.
Publicado: (2019)

Evaluation of Apoptosis, Cell Proliferation and Cell Cycle Progression by Inactivation of the NEAT1 Long Noncoding RNA in a Renal Carcinoma Cell Line Using CRISPR/Cas9
por: Haghighi, Nastaran, et al.
Publicado: (2023)

CRISPR/Cas9 genome editing for neurodegenerative diseases
por: Nouri Nojadeh, Jafar, et al.
Publicado: (2023)

Microfluidic Chips for Semen Analysis
por: Segerink, L.I., et al.
Publicado: (2012)

Electrophoretic separations on microfluidic chips
por: Wu, Dapeng, et al.
Publicado: (2008)

On chip microfluidic separation of cyclotides
por: DIDARIAN, Reza, et al.
Publicado: (2022)

Target RNA capture and cleavage by the Cmr type III-B CRISPR–Cas effector complex
por: Hale, Caryn R., et al.
Publicado: (2014)

CRISPR-Cas9 effectors facilitate generation of single-sex litters and sex-specific phenotypes
por: Douglas, Charlotte, et al.
Publicado: (2021)

Advanced CRISPR-Cas Effector Enzyme-Based Diagnostics for Infectious Diseases, Including COVID-19
por: Kwon, Sangha, et al.
Publicado: (2021)

Osteogenic Potential of Magnesium (Mg)-Doped Multicomponent Bioactive Glass: In Vitro and In Vivo Animal Studies
por: Kargozar, Saeid, et al.
Publicado: (2022)

Stem cell‐mediated angiogenesis in skin tissue engineering and wound healing
por: Azari, Zoleikha, et al.
Publicado: (2022)

The Application of Gene Expression Profiling in Predictions of Occult Lymph Node Metastasis in Colorectal Cancer Patients
por: Peyravian, Noshad, et al.
Publicado: (2018)

Influence of Diamond-Like Carbon Coating on the Channel Deformation of Injection-Molded Microfluidic Chips during the Demolding Process
por: Wang, Yilei, et al.
Publicado: (2020)

Characterization of a novel type III CRISPR-Cas effector provides new insights into the allosteric activation and suppression of the Cas10 DNase
por: Lin, Jinzhong, et al.
Publicado: (2020)

Measuring cell deformation by microfluidics
por: An, Ling, et al.
Publicado: (2023)

Kinetics of the CRISPR-Cas9 effector complex assembly and the role of 3′-terminal segment of guide RNA
por: Mekler, Vladimir, et al.
Publicado: (2016)

Efficient disruption and replacement of an effector gene in the oomycete P hytophthora sojae using CRISPR/Cas9
por: Fang, Yufeng, et al.
Publicado: (2015)

A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction
por: Han, Wenyuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_unr151pcr4769jq05pdc9tdgs6